美国Seracare HIV血清性能盘（HIV Performance Panels）

广州健仑生物科技有限公司

SeraCare Life Sciences公司主要在美国、欧洲和亚洲提供促进人类和动物诊断和治疗学的探索、开发和生产的产品和服务。其业务分为两个部分：诊断和生物制药产品和生物服务。诊断和生物制药产品部门生产和销售诊断和控制面板产品，用于测试传染性疾病的临床实验室及员工培训和能力测试。生物服务部门提供生物银行、来样加工和测试服务。

美国SeraCare收购BBI公司，即原BBI血清盘已经改名为SeraCare血清盘。

其产品包括有：传染病阳性质控品、疾病标准品、细菌阳性质控品、人血清白蛋白、人伽马球蛋白、牛血清白蛋白、血清盘、人血浆、人血清。

SeraCare的血清盘包括：HIV-1转化盘、HIV性能盘、HBV转化盘、HBV性能盘、HCV转化盘、HCV性能盘、弓形虫性能盘、线性盘和质控盘等等。

我司还提供其它进口或国产试剂盒：登革热、疟疾、流感、A链球菌、合胞病毒、腮病毒、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌、化妆品检测、食品安全检测等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品。

欢迎咨询

欢迎咨询2042552662

美国Seracare HIV血清性能盘（HIV Performance Panels）

美国Seracare 

想了解更多的产品及服务请扫描下方二维码：

【公司名称】 广州健仑生物科技有限公司

【市 场 部】    杨永汉

【】 

【腾讯Q Q】 2042552662

【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-103室

综上所述，该研究发现能量水平能够调节全反式维甲酸合成，这种调节作用主要是通过胰岛素和Foxo1影响Rdh表达实现的。这一研究成果对研究全反式维甲酸与胰岛素信号通路的相互作用在II型糖尿病等胰岛素相关疾病中的作用具有一定意义。
近日，A * STAR研究员确定了一种磷酸蛋白在促进健康细胞自毁和卵巢癌进展中的作用。磷酸蛋白PTP4A3已知在癌细胞中过表达，其可以作为生物标志物，用于疾病预后。
为了生长和扩散，癌细胞积极“劫持”一些人体的自然细胞过程(如自噬)。自噬对于维持健康的细胞是必要的。
自噬是通过细胞器即自噬体来完成的，自噬体的任务是“拆除”细胞，运输无用的细胞物质用于回收并组成新的膜和蛋白质。自噬过程中自噬体会经历成熟过程，这使得他们能够履行其有效的作用。
通过进行一系列的实验，科学家们已经发现在自噬过程中，PTP4A3过表达和自噬体成熟加速发生之间的。利用表达PTP4A3的卵巢癌细胞开展实验，结果发现PTP4A3利用自噬途径以促进癌细胞生长。
研究人员还发现，PTP4A3积聚在自噬体，加快其成熟过程。这反过来“鼓励”健康细胞的被破坏，并允许癌症“冒头”。
通过对卵巢癌患者数据进行分析，研究小组发现高水平的PTP4A3连同自噬基因与人类卵巢癌患者预后差显著相关。这意味着，PTP4A3水平可能在未来充当一个有用的生物标志物。此外，研究人员发现，抑制自噬能减少PTP4A3驱动癌细胞生长。

In summary, the study found that energy levels can modulate all-trans retinoic acid synthesis, and this regulation is mainly achieved through insulin and Foxo1 affecting Rdh expression. This research result has certain significance for studying the role of the interaction between all-trans retinoic acid and insulin signaling pathway in insulin-related diseases such as type II diabetes.
Recently, the A*STAR researcher determined the role of a phosphoprotein in promoting the self-destruction of healthy cells and the progression of ovarian cancer. The phosphoprotein PTP4A3 is known to be overexpressed in cancer cells, which can serve as a biomarker for disease prognosis.
In order to grow and spread, cancer cells actively "hijack" some of the body's natural cellular processes (such as autophagy). Autophagy is necessary to maintain healthy cells.
Autophagy is accomplished through organelles called autophagosomes. The task of autophagosomes is to "dismantle" cells and transport useless cellular material to recover and form new membranes and proteins. Autophagic processes undergo a maturation process during autophagy, which allows them to perform their effective role.
Through a series of experiments, scientists have discovered a link between PTP4A3 overexpression and accelerated autophagic maturation during autophagy. Using an ovarian cancer cell expressing PTP4A3 to perform the experiment, it was found that PTP4A3 utilizes an autophagy pathway to promote cancer cell growth.
The researchers also found that PTP4A3 accumulates in the autophagosome and accelerates its maturation process. This in turn "encourages" the destruction of healthy cells and allows cancer to "rise its head".
By analyzing the data of patients with ovarian cancer, the team found that high levels of PTP4A3 along with autophagy genes are significantly associated with poor prognosis in human ovarian cancer patients. This means that PTP4A3 levels may act as a useful biomarker in the future. In addition, the researchers found that inhibiting autophagy can reduce the growth of PTP4A3-driven cancer cells.